Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Erythromycin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erythromycin 250mg gastro-resistant tablets
0501050C0AAABAB
|
Erythromycin (Systemic) | Erythromycin | Infections | 59,172 |
|
Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion
1306010I0AAABAB
|
Erythromycin (Topical) | Erythromycin | Skin | 25,362 |
|
Zineryt lotion
1306010I0BCAAAB
|
Zineryt | Erythromycin | Skin | 9,764 |
|
Tretinoin 0.025% / Erythromycin 4% solution
1306010I0AAAFAF
|
Erythromycin (Topical) | Erythromycin | Skin | 1,629 |
|
Aknemycin Plus solution
1306010I0BFAAAF
|
Aknemycin Plus | Erythromycin | Skin | 762 |
|
Erythromycin 250mg gastro-resistant capsules
0501050C0AAAKAK
|
Erythromycin (Systemic) | Erythromycin | Infections | 137 |
|
Isotretinoin 0.05% / Erythromycin 2% gel
1306010I0AAACAC
|
Erythromycin (Topical) | Erythromycin | Skin | 44 |
|
Isotrexin gel
1306010I0BDAAAC
|
Isotrexin | Erythromycin | Skin | 18 |
|
Erythromycin 4% gel
1306010I0AAAEAE
|
Erythromycin (Topical) | Erythromycin | Skin | 16 |
|
Erymax 250mg gastro-resistant capsules
0501050C0BCAAAK
|
Erymax | Erythromycin | Infections | 1 |
|
Erythromycin 0.5% eye ointment
1103010I0AAAAAA
|
Erythromycin (Eye) | Erythromycin | Eye | 1 |
|
Eryacne 2 gel
1306010I0BEAAAD
|
Eryacne | Erythromycin | Skin | No data available |
|
Eryacne 4 gel
1306010I0BEABAE
|
Eryacne | Erythromycin | Skin | No data available |
|
Erythromycin 0.5% Ophthalmic Ointment
1103010I0BCAAAA
|
Erythromycin (Ophthalmic) | Erythromycin | Eye | No data available |
|
Erythromycin 2% gel
1306010I0AAADAD
|
Erythromycin (Topical) | Erythromycin | Skin | No data available |
|
Erythromycin 2% solution
1306010I0AAAAAA
|
Erythromycin (Topical) | Erythromycin | Skin | No data available |
|
Kerymax 250mg gastro-resistant capsules
0501050C0BLAAAK
|
Kerymax | Erythromycin | Infections | No data available |
|
Oftalmolosa Cusi Eritromicina 0.5% eye ointment
1103010I0BBAAAA
|
Oftalmolosa Cusi Eritromicina | Erythromycin | Eye | No data available |
|
Rommix 250 EC tablets
0501050C0BIAAAB
|
Rommix (Tablet) | Erythromycin | Infections | No data available |
|
Stiemycin 2% solution
1306010I0BBAAAA
|
Stiemycin | Erythromycin | Skin | No data available |
|
Tiloryth 250mg gastro-resistant capsules
0501050C0BKAAAK
|
Tiloryth | Erythromycin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.